Heart, Lung, Blood and Sleep Disorders
Last data update: May 08, 2024 . (Total: 47372 Documents since 2020)
Records 1-30 (of 65 Records) |
Query Trace: Myocardial Infarction[original query] |
---|
Relationship between serum lactate dehydrogenase levels and prognosis in patients infected with omicron and delta variants of COVID-19: A cross-sectional study. Ostadi Fatemeh, et al. Toxicology reports 2023 0 0. 368-373 |
Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster. Marie-Joelle Jabagi et al. N Engl J Med 2023 3 (15) 1431-1432
At 21 days after the booster dose, we found no evidence of an increased risk of cardiovascular events among the recipients of the bivalent vaccine as compared with recipients of the monovalent vaccine. The evaluated events included ischemic stroke (hazard ratio, 0.86; 95% confidence interval [CI], 0.58 to 1.27), hemorrhagic stroke (hazard ratio, 0.86; 95% CI, 0.46 to 1.61), myocardial infarction (hazard ratio, 0.92; 95% CI, 0.62 to 1.36), pulmonary embolism (hazard ratio, 0.83; 95% CI, 0.49 to 1.40), and all four events combined (hazard ratio, 0.87; 95% CI, 0.69 to 1.09).
|
Live to die another day: novel insights may explain the pathophysiology behind smoker's paradox in SARS-CoV-2 infection. Papadopoulos K I, et al. Molecular and cellular biochemistry 2023 0 0. 1-10 |
The results of thrombectomy from the arteries of the lower extremities in patients infected with SARS-CoV-2 Omicron variant with different severity of respiratory failure. Kazantsev Anton N, et al. Vascular 2023 0 0. 17085381231160933 |
Artificial intelligence based approach for categorization of COVID-19 ECG images in presence of other cardiovascular disorders. Chaitanya M Krishna, et al. Biomedical physics & engineering express 2023 0 0. |
COVID-19's influence on cardiac function: a machine learning perspective on ECG analysis. Gomes Juliana Carneiro, et al. Medical & biological engineering & computing 2023 0 0. |
The Effect of COVID-19 on the Perioperative Course of Acute Coronary Syndrome in Poland: The Estimation of Perioperative Prognosis and Neural Network Analysis in 243,515 Cases from 2020 to 2021. Kaziród-Wolski Karol, et al. Journal of clinical medicine 2022 0 0. (18) |
The Key Genes Underlying Pathophysiology Correlation Between the Acute Myocardial Infarction and COVID-19. You Hongjun, et al. International journal of general medicine 2022 0 0. 2479-2490 |
Effects of multimorbidity on incident COVID-19 events and its interplay with COVID-19 event status on subsequent incident myocardial infarction (MI). Lip Gregory Y H, et al. European journal of clinical investigation 2022 0 0. e13760 |
Kounis syndrome associated with BNT162b2 mRNA COVID-19 vaccine presenting as ST-elevation acute myocardial infarction. Sanci Emre, et al. Anatolian journal of cardiology 2022 0 0. (1) 69-74 |
Colchicine Against SARS-CoV-2 Infection: What is the Evidence? Drosos Alexandros A, et al. Rheumatology and therapy 2022 0 0. |
COV-ECGNET: COVID-19 detection using ECG trace images with deep convolutional neural network. Rahman Tawsifur, et al. Health information science and systems 2022 0 0. (1) 1 |
Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review. Zhang Fan-Shun, et al. Acta pharmacologica Sinica 2022 0 0. |
COVID-19 disease diagnosis from paper-based ECG trace image data using a novel convolutional neural network model. Irmak Emrah, et al. Physical and engineering sciences in medicine 2022 0 0. |
The Predictive Role of Artificial Intelligence-Based Chest CT Quantification in Patients with COVID-19 Pneumonia. Szabó István Viktor, et al. Tomography (Ann Arbor, Mich.) 2021 0 0. (4) 697-710 |
Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older MJ Jabagi et al, JAMA,November 22,2021
The BNT162b2 mRNA vaccine (Pfizer-BioNTech) was the first SARS-CoV-2 vaccine authorized and most widely used in older persons in France. Although no increases in cardiovascular events were reported in the phase 3 trials, questions emerged once the vaccine was used on a large scale because older people were underrepresented in the trials. In this nationwide study involving persons aged 75 years or older in France, no increase in the incidence of acute myocardial infarction, stroke, and pulmonary embolism was detected 14 days following each BNT162b2 mRNA vaccine dose.
|
Acute ST-Segment Elevation Myocardial Infarction as Initial Presentation of Atypical Hemolytic-Uremic Syndrome. Chau Edward, et al. JACC. Case reports 2021 0 0. (4) 561-565 |
Colchicine-new horizons for an ancient drug. Schattner Ami, et al. European journal of internal medicine 2021 0 0. |
COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD. Myers Kelly D, et al. American journal of preventive cardiology 2021 0 0. 100197 |
Surveillance for Adverse Events After COVID-19 mRNA Vaccination. Klein Nicola P et al. JAMA 2021 9 |
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. Barda Noam et al. The New England journal of medicine 2021 8
In this study in a nationwide mass vaccination setting in Israel, the BNT162b2 vaccine was not associated with an elevated risk of most of the adverse events examined. The vaccine was associated with an excess risk of myocarditis (1 to 5 events per 100,000 persons). The risk of this potentially serious adverse event and of many other serious adverse events was substantially increased after SARS-CoV-2 infection.
|
Direct Reprogramming Induces Vascular Regeneration Post Muscle Ischemic Injury. Kaur Keerat, et al. Molecular therapy : the journal of the American Society of Gene Therapy 2021 0 0. |
Understanding ST-Elevation Myocardial Infarction in COVID-19: The Marriage of Bench Work and Big Data. Siscel Jordan, et al. Journal of cardiothoracic and vascular anesthesia 2021 0 0. |
Protein S: function, regulation, and clinical perspectives. Majumder Rinku, et al. Current opinion in hematology 2021 0 0. |
Classification of COVID-19 electrocardiograms by using hexaxial feature mapping and deep learning Ozdemir, Mehmet Akif et al. Research Square May 28 2021 |
COV-ECGNET: COVID-19 detection using ECG trace images with deep
convolutional neural network Rahman, Tawsifur et al. arXiv June 01 2021 |
Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions. Nain Zulkar, et al. Briefings in bioinformatics 2021 0 0. |
Classification of COVID-19 electrocardiograms by using hexaxial feature mapping and deep learning. Ozdemir Mehmet Akif, et al. BMC medical informatics and decision making 2021 0 0. (1) 170 |
COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD KD Myers et al, AJPM, May 25, 2021
Our analyses confirm that pre-existing ASCVD is associated with increased risk of acute myocardial infarction in the setting of COVID-19. Additionally, we establish that both diagnosed and probable FH are associated with increased risk for AMI in the setting of COVID-19. Critically, our data indicate that those with both ASCVD and FH are at very high risk of AMI if they contract COVID-19.
|
High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL). Mariani Javier, et al. Trials 2021 0 0. (1) 111 |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 08, 2024
- Content source: